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These results indicate that CX3CR1 on resident vessel wall cells plays a key role in atherosclerotic plaque formation in transplanted aortic grafts. Targeting of vascular CX3CL1/ a1111111111 a1111111111 a1111111111 a1111111111 a1111111111
Introduction
Atherosclerosis is an inflammatory disease of the arteries with a high rate of morbidity and mortality in the Western World. The immune reactions involved in atherosclerotic plaque formation are controlled by lipid mediators, costimulatory molecules and cytokines. Chemokines are a family of chemotactic cytokines that mediate immune cell recruitment and are of high relevance in atherogenesis [1] , and targeting of chemokines and their receptors has been shown to reduce experimental atherosclerosis [2] [3] [4] . Fractalkine or CX3CL1 is a CX3C chemokine that is expressed in the vessel wall and mediates firm adhesion and chemotaxis of leukocytes expressing its G-protein-coupled receptor, CX3CR1. CX3CL1 is the only member of the CX3C chemokine family and is usually attached to the membrane through a mucin-like domain [5, 6] .
Fractalkine/CX3CL1 expression has been detected on activated endothelial cells, smooth muscle cells (SMCs), macrophages and platelets, and is involved in the development of numerous inflammatory pathologies including atherosclerosis, rheumatoid arthritis, or graft rejection [7] [8] [9] [10] [11] [12] [13] . While the expression of fractalkine and its receptor CX3CR1 is low in healthy vessels, it increases significantly under pathological conditions, such as in atherosclerotic plaques or during allograft rejection [11, 13] . In atherosclerotic vessels, its receptor CX3CR1 is expressed on monocytes and tissue resident SMCs. Mice deficient in CX3CR1 (Cx3cr -/-mice) have previously been employed to investigate the function of monocyte survival and recruitment during atherogenesis [14, 15] . The CX3CL1-CX3CR1 interaction has been shown to confer essential survival signals in monocytes/macrohages, and absence of CX3CR1 was shown to lead to an increased death of monocytes and/or foam cells, inhibiting atherosclerotic lesion formation [15] . Pharmacological inhibition of the chemokine receptor, CX3CR1 has furthermore been described to inhibit leukocyte recruitment and to reduce atherosclerosis [16] , indicating an important role of CX3CL1 in the pathogenesis of atherosclerosis. In addiiton, platelets express CX3CR1, which plays a role in the formation of platelet-monocyte complexes [10] . Moreover, CX3CL1/Fractalkine can elicit chemotactic responses in SMCs and has been described to exert anti-apoptotic and proliferative effects on human vascular SMC [6, 11] . Effects of a deficiency of CX3CL1/CX3CR1 or its blockade in vivo, however, do not allow a discriminatation of local from systemic effects. In this regard, murine aortic transplant models have attracted great attention as these allow studying specific vascular responses caused by the graft itself separate from systemic factors related to the recipient (atherogenic) environment [17] [18] [19] .
In this study, we focused on the function of CX3CR1 in the atherosclerotic response within an aortic segment graft orthotopically transplanted in mice. This allowed us to investigate the role of vascular CX3CR1 versus systemic CX3CR1 to gain further insight into the details of how this chemokine receptor controls atherosclerotic plaque formation.
Methods
Aortic transplantation
Apoe
-/-mice (C57BL/6 background) were crossed with Cx3cr1 -/- [20] Apoe -/-mice (n = 5). After transplantation, mice were placed on atherogenic diet (21% fat, 0.15% cholesterol, Altromin) for four weeks. The abdominal aortic transplantation was performed as described previously using the sleeve technique [17, 21] . Briefly, mice were anesthetized using a mixture of 1.5 vol. % isoflurane and 100% oxygen through a face mask. The segment of aorta between the renal arteries and its bifurcation was separated from the vena cava. The infrarenal aorta of the recipient was dissected and mobilized between the renal arteries proximally and the bifurcation distally. All the small branches of this segment were secured. The proximal and distal portions of the aorta were clamped by 6/0 single silk suture (Silk, Deknatel, Research Triangle Park NC, USA). The graft was placed in the orthotopic position and the anastomosis was performed using the sleeve technique with sutures 11/0 monofilament (Ethilon, Ethicon, Norderstedt, Germany). The mean surgical anastomosis time was 22 minutes (range 13-40 minutes). Donor and recipient mice were of the same age (8-12 weeks).
Immunohistochemistry
For tissue harvesting, animals were anesthetized (with a mixture of 1.5 vol. % isoflurane and 100% oxygen via a face mask) and vessels were flushed with phosphate-buffered saline (PBS) followed by 4% formaldehyde/PBS (pH 7.4) by cardiac puncture. Grafts were gently removed. After overnight fixation in 4% formaldehyde/PBS, specimens were further processed and embedded in paraffin. Serial sections (5 μm) throughout the transplanted aorta distal and proximal of the anastomosis sites were stained by hematoxylin and eosin staining (HE). Immunocytochemistry was performed using antibodies raised against macrophages (Mac2, CL8942AP/Cedarlane), vascular smooth muscle cells (SMA, M0851/Dako) followed by antirat FITC (Jackson Immuno-Research, West Grove, USA) and anti-mouse-Cy3, respectively, antigen KI-67 for cellular proliferation (KI-67, M7249/Dako, Jena, Germany) and TUNEL for detecting DNA fragmentation (1215679210/Roche; 11684795910/Roche, Mannheim, Germany). Positively stained cells were counted in higher magnification (40x) and expressed as percent from total DAPI stained nuclei or as absolute numbers per mm 2 (S1A and S1B Fig) .
Statistics
Data are presented as mean ± SEM. Immunostaining further revealed that this decrease in atherosclerotic plaque size in Cx3cr1 -/-Apoe -/-aortic segments was associated with a significant reduction in the number of smooth muscle actin (SMA) + SMCs in plaques of the aortic segment (Fig 2A, S1C Fig) . The presence of SMA + SMCs mostly in the intima during plaque formation may indicate that SMCs in the media differentiate towards a synthetic phenotype during vessel inflammation and plaque formation [22] . In contrast, lesional Mac2 + macrophage numbers were not significantly altered between groups (Fig 2B, S1D Fig) . These findings suggest that CX3CR1 expressed by vessel wall-resident SMCs is required for atherosclerotic plaques growth in transplanted vessels, whereas its expression on circulating cells and macrophages seems to play a subordinate role. Furthermore, we assessed cell proliferation by Ki-67 staining in all plaque cells and apoptosis by TUNEL staining in all plaque cells but could not detect significant differences between groups (S1E and S1F Fig).
Discussion
We here employed a model of orthotopic transplantation of an infrarenal aortic segment into the infrarenal aorta of recicpient mice. Unlike in bone marrow transplantation models, which can be used to dissect the contribution of bone marrow versus non-bone marrow cells (including vessel wall cells but also all resident cells in other organs), this model allows to focus on the particular contribution of local (transferred) cells within the graft. Using this aorta transplantation model to discriminate between effects of circulating versus local vessel wall resident cells, we here are able to show that interference with the CX3CR1-driven signaling pathway in vessel wall cells inhibits atherosclerotic lesion formation. [23, 24] , associated with a reduction in macrophage accumulation in plaques [23, 24] . Saederup et al. showed that the deletion of CX3CL1 in CCR2-deficient mice reduced the accumulation of macrophages and the development of atherosclerosis [25] . In accordance, Combadière et al. demonstrated that the combined inhibition of CCL2, CX3CR1, and CCR5 in Apoe -/-mice was associated with a marked and additive reduction in atherosclerosis [26] . The site-specific action of CX3CR1 was not addressed in these studies. However, also bone marrow deficiency of CX3CR1 reduced atherosclerotic lesion formation in chimeric Apoe -/-mice, and the CX3CL1/CX3CR1 signaling pathway was uncovered to exert pro-survival signals in macrophages, whose absence leads to the increased death of monocytes/foam cells during plaque growth [15] . In contrast to these findings, we did not observe significant alterations in plaque size or lesional macrophage accumulation in Cx3cr1 -/-Apoe -/-mice transplanted with Apoe -/-mice that entail a deficiency in CX3CR1 in circulating leukocytes. This may be due to specificities of the transplantation model that produces plaques that predominantly contain SMCs rather than macrophages in the infrarenal abdominal aorta.
The interaction of SMCs with monocytes induces a significant up-regulation of CX3CR1 gene and protein expression in both cell types [27] . Moreover, CX3CL1 gene and protein expression increases in the murine aorta in high-fat vs normal diet fed Apoe -/-mice [28] . Notably, CX3CL1 has been demonstrated to exert anti-apoptotic and proliferative effects on vascular cells, mediated via EGFR, with antagonists of CX3CR1 abrogating the proliferative effects of CX3CL1 in SMCs [6] . Deficiency of CX3CR1 may similarly have curtailed CX3CL1-mediated SMC proliferation, in turn inhibiting intimal hyperplasia. However, we cannot rule out the involvement of other vessel wall cells, given that we did not observe changes in SMC or proliferating cells relative to the plaque area. For instance, resident myeloid cells that accumulate CX3R1-dependently in the vessel wall [29] may have contributed to the phenotype observed. Clinically, stability of an atherosclerotic plaque is an important characteristic [30] . Unstable atherosclerotic plaques are characterized by high numbers of macrophages and decreased SMC and collagen content. These plaques are more likely to undergo rupture and cause vessel thrombosis when compared to SMC and collagen-rich stable plaques [30] . Our findings that a decrease in atherosclerotic plaque size in Cx3cr1 -/-Apoe -/-aortic segments was associated lower numbers of SMCs may indicate that inhibition of CX3CR1 may also have unfavorable effects on plaque stability. On the other hand, confining SMC proliferation is major challenge in vascular remodeling after percutanous transluminal coronary angioplasty and stent-implantation [31] . In this regard, targeting CX3CR1 may be a potent therapeutic target limiting monocyte accumulation [15, 23, 24] and SMC proliferation. An increased expression of CX3CL1 and CX3CR1 has been found in coronary arteries from patients after heart transplantation, and several studies have suggested a role of CX3CR1 in allograft rejection and dysfunction [13, [32] [33] [34] . For instance, Robinson et al. observed a prolonged in vivo survival of heterotopic murine cardiac allograft transplants in a major histocompatibility complex-mismatch model, when treated with CX3CR1-antibodies [13] . In our study, however, both donors and recipients were of the C57BL/6 background, excluding the possibility that (CX3CR1-dependent) graft versus host responses may have affected atherosclerotic lesion development in our transplant model.
A clear limitation of our study are the low n-numbers that may have precluded reaching more definite statistical conclusions. In particular, the trend of reduced plaque burden in Apoe-/-aortic segments transplanted into Cx3cr1-/-Apoe-/-mice compared to control Apoe-/-aortic segments in Apoe-/-mice may have substantiated when group sized were lager. Similarly, the cellular plaque characterization yielded values with a wide distribution, so that significant differences between groups may have been missed. Moreover, an additional group of mice with Cx3cr1 -/-donors and Cx3cr1 -/-recipients is missing to evaluate the complete absence of Cx3cr1 and possible additive effects in our model. Taken together we here unveil an important function of CX3CR1 in resident vessel wall cells to promote atherosclerotic lesion growth in the transplanted abdominal aorta in Apoe -/-mice. Targeting CX3CL1/ CX3CR1 may thus be viable therapeutic option in vascular transplantation procedures. 
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